Fundamentals and stats
OSE Immunotherapeutics SA financial statements, including revenue, expenses, and profit
The total revenue of OSE for the last semiannual is 1.32 M EUR, and it's 59.21% higher compared to the previous semiannual. The net income of H1 25 is -15.11 M EUR.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM